The U.S. Food and Drug Administration issued its full approval of the Pfizer covid-19 vaccine Monday. The move comes eight months after the Pfizer vaccine was authorized for emergency use in the ...
On Monday morning, the FDA gave full approval to the Pfizer covid-19 vaccine. This is an even faster approval than Pfizer has hoped for, as the most optimistic date had been early September. Until now ...
The 2025-2026 COVID-19 vaccine formulation targets the SARS-CoV-2 sublineage LP.8.1, in line with FDA guidance to more closely match circulating strains1 Shipping of the LP.8.1-adapted vaccine will ...
In a vote of 16-2, a key Food and Drug Administration (FDA) panel rejected a plan to approve Pfizer booster shots. The Associated Press reports that the panel voiced frustration that Pfizer had ...